Editorial commentary: Atrial fibrillation in patients with cardiomyopathy – Protecting the vulnerable
Authors:
- 11 March 2025
- journal article
- Published by Elsevier in Trends in Cardiovascular Medicine
- Vol. 35 (5) , 294-296
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Minimum National Prevalence of Diagnosed Atrial Fibrillation Inferred From California Acute Care FacilitiesJACC, 2024
- Atrial Fibrillation as a Prognostic Factor for All-Cause Mortality in Patients With Transthyretin Amyloid CardiomyopathyJACC: Cardiooncology, 2024
- Implications of Atrial Fibrillation for Guideline-Directed Therapy in Patients With Heart FailureJACC, 2024
- Atrial fibrillation: epidemiology, screening and digital healthThe Lancet Regional Health - Europe, 2024
- 2022 AHA/ACC/HFSA Guideline for the Management of Heart FailureJACC, 2022
- The role of atrial fibrillation catheter ablation in patients with heart failureProgress in Cardiovascular Diseases, 2021
- Atrial Fibrillation, Anticoagulation Management and Risk of Stroke in the Cardiomyopathy/Myocarditis Registry of the EURObservational Research Programme of the European Society of CardiologyESC Heart Failure, 2020
- US Health Care Spending by Payer and Health Condition, 1996-2016JAMA, 2020
- Current Evidence-Based Understanding of the Epidemiology, Prevention, and Treatment of Atrial FibrillationCurrent Problems in Cardiology, 2018
- Arrhythmogenic Right Ventricular CardiomyopathyJACC, 2016